Ignyta founder boosts team at his new cancer startup; Cytomx CMO hits the exit
→ Ignyta founder and ex-CEO Jonathan Lim is beefing up the team at Erasca, his new startup dedicated to erasing cancer. Genentech vet Gary Yeung has been promoted to chief operating and financial officer, leaving an open CBO role for David Chacko to step in. Chacko joins from Versant Ventures, where, as a principal, he was credited for advancing several portfolio companies through fundraising, business development and other affairs. Les Brail, who has been working on Neon’s personalized neoantigen vaccine, will be the VP of clinical development; Karen Gilmore, one of Lim’s old colleagues at Ignyta, has been tapped as VP of finance.